BHF Kleinwort Benson Group’s Edwards Lifesciences EW Stock Holding History

BHF Kleinwort Benson Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,600	Closed	-$299K	–	417
2015 Q3	$299K	Buy	+12,600	New	+$304K	0.01%	305
2015 Q2	–	Sell	-17,100	Closed	-$406K	–	407
2015 Q1	$406K	Sell	17,100 -50,100	-75%	-$1.12M	0.01%	329
2014 Q4	$1.45M	Buy	67,200 +39,000	+138%	+$784K	0.04%	233
2014 Q3	$382K	Buy	+28,200	New	+$445K	0.01%	331

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BHF Kleinwort Benson Group's EW Position: Q4 2015 in Review

BHF Kleinwort Benson Group sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 12,600 shares — an estimated $299K sold.

BHF Kleinwort Benson Group first reported a position in EW in Q3 2014 and held it in 4 quarters. The position peaked at $1.45M in Q4 2014. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

BHF Kleinwort Benson Group reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
BHF Kleinwort Benson Group sold 12,600 Edwards Lifesciences shares in Q4 2015, an estimated $299K.
BHF Kleinwort Benson Group first reported a position in Edwards Lifesciences in Q3 2014 and held it in 4 quarters.
BHF Kleinwort Benson Group's Edwards Lifesciences position peaked at $1.45M in Q4 2014.
605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on BHF Kleinwort Benson Group's 13F filing for Q4 2015, filed 9 Feb 2016.